These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Clinical presentations of nontuberculous mycobacteria as suspected and drug-resistant tuberculosis: Experience from a tertiary care center in Eastern India. Das S; Mishra B; Mohapatra PR; Preetam C; Rath S Int J Mycobacteriol; 2022; 11(2):167-174. PubMed ID: 35775549 [TBL] [Abstract][Full Text] [Related]
45. Epidemiology and risk factors associated with NTM pulmonary and extrapulmonary infections in a high tuberculosis endemic Region. Wani SR; Wattal C; Raveendran R Indian J Med Microbiol; 2020; 38(2):169-175. PubMed ID: 32883930 [TBL] [Abstract][Full Text] [Related]
48. Preclinical murine models to study lung infection with Mycobacterium abscessus complex. Nicola F; Cirillo DM; Lorè NI Tuberculosis (Edinb); 2023 Jan; 138():102301. PubMed ID: 36603391 [TBL] [Abstract][Full Text] [Related]
49. Nontuberculous mycobacteria testing and culture positivity in the United States. Marshall JE; Mercaldo RA; Lipner EM; Prevots DR BMC Infect Dis; 2024 Mar; 24(1):288. PubMed ID: 38448840 [TBL] [Abstract][Full Text] [Related]
50. Eradication of Nontuberculous Mycobacteria in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Cohort Study. Wiesel V; Aviram M; Mei-Zahav M; Dotan M; Prais D; Cohen-Cymberknoh M; Gur M; Bar-Yoseph R; Livnat G; Goldbart A; Hazan G; Hazan I; Golan-Tripto I J Cyst Fibros; 2024 Jan; 23(1):41-49. PubMed ID: 37173154 [TBL] [Abstract][Full Text] [Related]
51. Epidemiology of Nontuberculous Mycobacteria in Tuberculosis suspects, Southwest of China, 2017-2022. Wang DM; Liu H; Zheng YL; Xu YH; Liao Y Front Cell Infect Microbiol; 2023; 13():1282902. PubMed ID: 38029240 [TBL] [Abstract][Full Text] [Related]
52. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. van Ingen J; Boeree MJ; van Soolingen D; Mouton JW Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524 [TBL] [Abstract][Full Text] [Related]
53. Extremely Low Hit Rate in a Diverse Chemical Drug Screen Targeting Mycobacterium abscessus. Malin JJ; Winter S; van Gumpel E; Plum G; Rybniker J Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427298 [No Abstract] [Full Text] [Related]
54. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Johansen MD; Herrmann JL; Kremer L Nat Rev Microbiol; 2020 Jul; 18(7):392-407. PubMed ID: 32086501 [TBL] [Abstract][Full Text] [Related]
55. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections. Brown-Elliott BA; Mann LB; Hail D; Whitney C; Wallace RJ Cornea; 2012 Aug; 31(8):900-6. PubMed ID: 22362004 [TBL] [Abstract][Full Text] [Related]
56. Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease? Ruth MM; Koeken VACM; Pennings LJ; Svensson EM; Wertheim HFL; Hoefsloot W; van Ingen J J Antimicrob Chemother; 2020 Mar; 75(3):609-617. PubMed ID: 31886864 [TBL] [Abstract][Full Text] [Related]
57. Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria. Das S; Garg T; Chopra S; Dasgupta A J Antimicrob Chemother; 2019 May; 74(5):1317-1322. PubMed ID: 30753528 [TBL] [Abstract][Full Text] [Related]
58. Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. Fröberg G; Maurer FP; Chryssanthou E; Fernström L; Benmansour H; Boarbi S; Mengshoel AT; Keller PM; Viveiros M; Machado D; Fitzgibbon MM; Mok S; Werngren J; Cirillo DM; Alcaide F; Hyyryläinen HL; Aubry A; Andres S; Nadarajan D; Svensson E; Turnidge J; Giske CG; Kahlmeter G; Cambau E; van Ingen J; Schön T; Clin Microbiol Infect; 2023 Jun; 29(6):758-764. PubMed ID: 36813087 [TBL] [Abstract][Full Text] [Related]
59. Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against Lee DG; Hwang YH; Park EJ; Kim JH; Ryoo SW Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681686 [No Abstract] [Full Text] [Related]
60. Implication of species change of Nontuberculous Mycobacteria during or after treatment. Lee JS; Lee JH; Yoon SH; Kim TS; Seong MW; Han SK; Yim JJ BMC Pulm Med; 2017 Dec; 17(1):213. PubMed ID: 29262802 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]